Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct 16:7:121-131.
doi: 10.1016/j.bonr.2017.10.003. eCollection 2017 Dec.

Is osteoporosis an autoimmune mediated disorder?

Rosebella A Iseme  1   2 , Mark Mcevoy  2   3 , Brian Kelly  2   4 , Linda Agnew  5 , Frederick R Walker  2   6   7 , John Attia  2   3   8
Affiliations
Review

Is osteoporosis an autoimmune mediated disorder?

Rosebella A Iseme et al. Bone Rep. .

Abstract

The last two decades have marked a growing understanding of the interaction occurring between bone and immune cells. The chronic inflammation and immune system dysfunction commonly observed to occur during the ageing process and as part of a range of other pathological conditions, commonly associated with osteoporosis has led to the recognition of these processes as important determinants of bone disease. This is further supported by the recognition that the immune and bone systems in fact share regulatory mechanisms and progenitor molecules. Research into this complex synergy has provided a better understanding of the immunopathogenesis underlying bone diseases such as osteoporosis. However, existing research has largely focussed on delineating the role played by inflammation in pathogenic bone destruction, despite increasing evidence implicating autoantibodies as important drivers of osteoporosis. This review shall attempt to provide a comprehensive overview of existing research examining the role played by autoantibodies in osteoporosis in order to determine the potential for further research in this area. Autoantibodies represent promising targets for the improved treatment and diagnosis of inflammatory bone loss.

Keywords: Autoantibodies; Bone mineral density; Bone remodelling; Fractures; Osteoporosis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Key inflammatory mediators implicated in the regulation of bone remodelling.
See this image and copyright information in PMC

References

    1. Aeschlimann D., Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb. Haemost. 1994;71:402e15. - PubMed
    1. Agardh D., Bjorck S., Agardh C.-D., Lidfeldt J. Coeliac disease-specific tissue transglutaminase autoantibodies are associated with osteoporosis and related fractures in middle-aged women. Scand. J. Gastroenterol. 2009;44(5):571–578. - PubMed
    1. Alenius G.M., Berglin E., Dahlqvist S.R. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann. Rheum. Dis. 2006;65(3):398–400. - PMC - PubMed
    1. Alves C.H., Farrell E., Vis M., Colin E.M., Lubberts E. Animal models of bone loss in inflammatory arthritis: from cytokines in the bench to novel treatments for bone loss in the bedside—a comprehensive review. Clin Rev Allergy Immunol. 2016;51:27–47. - PMC - PubMed
    1. Baron R. Anatomy and Ultrastructure of Bone – Histogenesis, Growth and Remodeling. In: De Groot L.J., Chrousos G., Dungan K., editors. Endotext [Internet] MDText.com, Inc.; South Dartmouth (MA): 2000. https://www.ncbi.nlm.nih.gov/books/NBK279149/ [Updated 2008 May 13] Available at.

LinkOut - more resources